NAMRATA CHIGURUPATI

      DIN: 07432180

      For latest information about the director, visit MCA.

      NAMRATA CHIGURUPATI is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 07432180. NAMRATA CHIGURUPATI is/has been associated with 15 companies.

      This is just one Director. Want to discover lot more?

      Unlock deeper insights with Prime Research AI

      Companies Associated With

      Company Designation Date of Appointment
      PERNIKA TASYA HEALTHCARE SERVICES PRIVATE LIMITED Director 19-Mar-2020

      Past Companies Associated With

      Company Designation Date of Appointment Date of Cessation
      BIBI ONCOLOGY SERVICES PRIVATE LIMITED Additional Director 09-Sep-2019 31-Dec-2020
      BIBI ONCOLOGY SERVICES PRIVATE LIMITED Director 31-Dec-2020 30-Mar-2021
      KAKATIYA INSTITUTE OF ONCOLOGY PRIVATE LIMITED Additional Director 05-Aug-2019 28-Sep-2019
      KAKATIYA INSTITUTE OF ONCOLOGY PRIVATE LIMITED Director 28-Sep-2019 07-Dec-2023
      ONCOCHAIN HEALTHCARE SERVICES PRIVATE LIMITED Additional Director 07-Dec-2020 07-Sep-2021
      ONCOCHAIN HEALTHCARE SERVICES PRIVATE LIMITED Director 07-Sep-2021 07-Dec-2023
      OMEGA CENTURY INSTITUTE OF ONCOLOGY PRIVATE LIMITED Additional Director 14-Nov-2018 28-Sep-2019
      OMEGA CENTURY INSTITUTE OF ONCOLOGY PRIVATE LIMITED Director 28-Sep-2019 07-Dec-2023
      HYDERABAD INSTITUTE OF ONCOLOGY PRIVATE LIMITED Additional Director 03-Oct-2016 29-Sep-2017
      HYDERABAD INSTITUTE OF ONCOLOGY PRIVATE LIMITED Director 29-Sep-2017 16-Mar-2020
      SATHAVAHANA INSTITUTE OF ONCOLOGY PRIVATE LIMITED Additional Director 09-Dec-2020 06-Sep-2021
      SATHAVAHANA INSTITUTE OF ONCOLOGY PRIVATE LIMITED Director 06-Sep-2021 07-Dec-2023
      DAKSHAYANI HEALTHCARE SERVICES PRIVATE LIMITED Additional Director 01-Jan-2021 30-Nov-2021
      DAKSHAYANI HEALTHCARE SERVICES PRIVATE LIMITED Director 30-Nov-2021 29-Mar-2022

      “Assess financial performance of all companies under a director.”

      Explore Prime Research Explore for Sales